This review focuses on the interconnection between mitochondrial function and dynamics with central and peripheral neuropeptide Y actions and discusses possible therapeutical modulations of the neuropeptide Y system as an anti-obesity tool. Here, NPY is linked to obesity due to melanocortin 4 receptor deficiency.